314 related articles for article (PubMed ID: 12886054)
1. Antimicrobials as potential adjunctive agents in the treatment of biofilm infection with Staphylococcus epidermidis.
Peck KR; Kim SW; Jung SI; Kim YS; Oh WS; Lee JY; Jin JH; Kim S; Song JH; Kobayashi H
Chemotherapy; 2003 Jul; 49(4):189-93. PubMed ID: 12886054
[TBL] [Abstract][Full Text] [Related]
2. Multiple combination bactericidal testing of staphylococcal biofilms from implant-associated infections.
Saginur R; Stdenis M; Ferris W; Aaron SD; Chan F; Lee C; Ramotar K
Antimicrob Agents Chemother; 2006 Jan; 50(1):55-61. PubMed ID: 16377667
[TBL] [Abstract][Full Text] [Related]
3. The inhibition of Staphylococcus epidermidis biofilm formation by vancomycin-modified titanium alloy and implications for the treatment of periprosthetic infection.
Antoci V; Adams CS; Parvizi J; Davidson HM; Composto RJ; Freeman TA; Wickstrom E; Ducheyne P; Jungkind D; Shapiro IM; Hickok NJ
Biomaterials; 2008 Dec; 29(35):4684-90. PubMed ID: 18814909
[TBL] [Abstract][Full Text] [Related]
4. Inefficacy of vancomycin and teicoplanin in eradicating and killing Staphylococcus epidermidis biofilms in vitro.
Claessens J; Roriz M; Merckx R; Baatsen P; Van Mellaert L; Van Eldere J
Int J Antimicrob Agents; 2015 Apr; 45(4):368-75. PubMed ID: 25614358
[TBL] [Abstract][Full Text] [Related]
5. Farnesol as antibiotics adjuvant in Staphylococcus epidermidis control in vitro.
Gomes F; Leite B; Teixeira P; Cerca N; Azeredo J; Oliveira R
Am J Med Sci; 2011 Mar; 341(3):191-5. PubMed ID: 21107231
[TBL] [Abstract][Full Text] [Related]
6. Confocal laser scanning microscopy analysis of S. epidermidis biofilms exposed to farnesol, vancomycin and rifampicin.
Cerca N; Gomes F; Pereira S; Teixeira P; Oliveira R
BMC Res Notes; 2012 May; 5():244. PubMed ID: 22591918
[TBL] [Abstract][Full Text] [Related]
7. Time-kill efficacy of antibiotics in combination with rifampin against Staphylococcus epidermidis biofilms.
Gagnon RF; Richards GK; Kostiner GB
Adv Perit Dial; 1994; 10():189-92. PubMed ID: 7999824
[TBL] [Abstract][Full Text] [Related]
8. Activity of glycopeptides in combination with amikacin or rifampin against Staphylococcus epidermidis biofilms on plastic catheters.
Pascual A; Ramirez de Arellano E; Perea EJ
Eur J Clin Microbiol Infect Dis; 1994 Jun; 13(6):515-7. PubMed ID: 7957277
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial activity of tigecycline alone or in combination with rifampin against Staphylococcus epidermidis in biofilm.
Szczuka E; Kaznowski A
Folia Microbiol (Praha); 2014 Jul; 59(4):283-8. PubMed ID: 24390796
[TBL] [Abstract][Full Text] [Related]
10. Electromagnetic augmentation of antibiotic efficacy in infection of orthopaedic implants.
Pickering SA; Bayston R; Scammell BE
J Bone Joint Surg Br; 2003 May; 85(4):588-93. PubMed ID: 12793569
[TBL] [Abstract][Full Text] [Related]
11. Biofilm formation is not necessary for development of quinolone-resistant "persister" cells in an attached Staphylococcus epidermidis population.
Knobloch JK; Von Osten H; Horstkotte MA; Rohde H; Mack D
Int J Artif Organs; 2008 Sep; 31(9):752-60. PubMed ID: 18924086
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of antibiotics alone for orthopaedic device related infections.
Isiklar ZU; Darouiche RO; Landon GC; Beck T
Clin Orthop Relat Res; 1996 Nov; (332):184-9. PubMed ID: 8913162
[TBL] [Abstract][Full Text] [Related]
13. Effect of Antimicrobial and Physical Treatments on Growth of Multispecies Staphylococcal Biofilms.
Stewart EJ; Payne DE; Ma TM; VanEpps JS; Boles BR; Younger JG; Solomon MJ
Appl Environ Microbiol; 2017 Jun; 83(12):. PubMed ID: 28411222
[TBL] [Abstract][Full Text] [Related]
14. Ultrasonically enhanced vancomycin activity against Staphylococcus epidermidis biofilms in vivo.
Carmen JC; Roeder BL; Nelson JL; Beckstead BL; Runyan CM; Schaalje GB; Robison RA; Pitt WG
J Biomater Appl; 2004 Apr; 18(4):237-45. PubMed ID: 15070512
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of daptomycin versus vancomycin in an experimental model of foreign-body and systemic infection caused by biofilm producers and methicillin-resistant Staphylococcus epidermidis.
Domínguez-Herrera J; Docobo-Pérez F; López-Rojas R; Pichardo C; Ruiz-Valderas R; Lepe JA; Pachón J
Antimicrob Agents Chemother; 2012 Feb; 56(2):613-7. PubMed ID: 22123684
[TBL] [Abstract][Full Text] [Related]
16. Synergy between protamine and vancomycin in the treatment of Staphylococcus epidermidis biofilms.
Lee CK; Rubin LG; Moldwin RM
Urology; 1995 Apr; 45(4):720-4. PubMed ID: 7716861
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of oritavancin in combination with rifampin or gentamicin against prosthetic joint infection-associated methicillin-resistant Staphylococcus epidermidis biofilms.
Yan Q; Karau MJ; Raval YS; Patel R
Int J Antimicrob Agents; 2018 Nov; 52(5):608-615. PubMed ID: 30048689
[TBL] [Abstract][Full Text] [Related]
18. Staphylococcus epidermidis biofilms control by N-acetylcysteine and rifampicin.
Leite B; Gomes F; Teixeira P; Souza C; Pizzolitto E; Oliveira R
Am J Ther; 2013; 20(4):322-8. PubMed ID: 21519220
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of MBEC™-HTP biofilm model for studies of implant associated infections.
Coraça-Hubér DC; Fille M; Hausdorfer J; Pfaller K; Nogler M
J Orthop Res; 2012 Jul; 30(7):1176-80. PubMed ID: 22228044
[TBL] [Abstract][Full Text] [Related]
20. Eradication of Staphylococcus epidermidis within Biofilms: Comparison of Systemic versus Supratherapeutic Concentrations of Antibiotics.
Daffinee KE; Piehl EC; Bleick C; LaPlante KL
Antimicrob Agents Chemother; 2023 Jun; 67(6):e0010823. PubMed ID: 37154699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
